The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 28 February 2025 | Viewed by 333
Special Issue Editor
Interests: evidence-based medicine; infectious diseases; meta-analysis; antimicrobial stewardship; nosocomial infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Although the COVID-19 pandemic has demonstrated how emerging and re-emerging pathogens represent an existential menace to humankind, the issue of antimicrobial resistance (AMR) looms as the perennial threat of this century.
The main setting where AMR unfolds is obviously the nosocomial setting.
In many countries, there are alarming rates of multidrug-resistant (MDR), extensively drug-resistant (XDR), or difficult-to-treat (DTR) pathogens among both Gram-negative and Gram-positive bacteria.
The robust knowledge of epidemiology, resistance mechanisms, and available therapeutic options against superbugs is crucial to guarantee the best management of patients affected by invasive infections produced by these pathogens.
This Special Issues aims to collect reviews and original articles addressing these topics to offer new insights from different viewpoints: epidemiological, aetiological, diagnostic, prognostic, and therapeutic.
Dr. Alberto Enrico Maraolo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- MDR
- XDR
- DTR
- nosocomial infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
